Good Review Management Guidance Focuses On PDUFA Sponsor Involvement
This article was originally published in The Tan Sheet
Executive Summary
Responsibility for pre-submission phase management during drug development remains with the sponsor, FDA reiterates in its final Good Review Management Principles guidance on PDUFA products